Yarrow Bioscience, Inc. (YARW) stock
YARWNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 13, 2026Score 11/30102% above fair value
$14.21+0.28 (+2.01%)
Close on Nov 17, 2026Market cap $37.94MP/E –Yield –
Yarrow Bioscience enterprise value
Enterprise value is market cap plus debt, minus cash: the value of the whole business to all its investors.
Yarrow Bioscience's enterprise value was -$10.86M on Nov 11, 2026, against -$32.03M a year earlier. Over the last 5 years it ranged from -$61.87M to $1.68M, with a median of -$22.01M.
Enterprise Value at the end of each year
| Period | Period end | Value | Change |
|---|---|---|---|
| 2026 | Nov 11, 2026 | -$10.86M | – |
| 2025 | Dec 31, 2025 | -$28.18M | – |
| 2024 | Dec 31, 2024 | -$20.77M | – |
| 2023 | Dec 29, 2023 | -$7.75M | – |
| 2022 | Dec 30, 2022 | -$26.81M | -1699.1% |
| 2021 | Dec 31, 2021 | $1.68M | -99.2% |
| 2020 | Dec 31, 2020 | $221.32M | +1524.1% |
| 2019 | Dec 31, 2019 | $13.63M | – |
| 2018 | Dec 31, 2018 | -$56.95M | – |
See a number that looks wrong?